about
AQP1 is not only a water channel: it contributes to cell migration through Lin7/beta-cateninRole of the Number of Microtubules in Chromosome Segregation during Cell DivisionNavigation Strategies of Motor Proteins on Decorated TracksMolecular mechanisms triggered by mercuryBursts of activity in collective cell migration.CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.Integrative analysis of pathway deregulation in obesityConformational mechanism for the stability of microtubule-kinetochore attachments.Cellular targets for anticancer strategies.Marine-derived collagen biomaterials from echinoderm connective tissues.Cancer stem cells and therapeutic perspectives.Drug resistance in melanoma: new perspectives.The water channels, new druggable targets to combat cancer cell survival, invasiveness and metastasis.Targeting cancer stem cells to modulate alternative vascularization mechanisms.Human breast and melanoma cancer stem cells biomarkers.CXCR6: the role of environment in tumor progression. Challenges for therapy.Probing spermiogenesis: a digital strategy for mouse acrosome classification.Biophysical processes in fibrosis: Comment on: "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Carlo Bianca and Martine Ben Amar.Carbon nanopowder acts as a Trojan-horse for benzo(α)pyrene in Danio rerio embryos.Complexity in cancer stem cells and tumor evolution: Toward precision medicine.Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposureMelanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.Protein accumulation in the endoplasmic reticulum as a non-equilibrium phase transition.Effect of glucose stress conditions in BL6T murine melanoma cells.Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential.Cholesterol impairment contributes to neuroserpin aggregation.c-PKC-dependent modulation of plasma fibrinogen levels during the acute-phase response in young and old rats.Gating mechanism of the nuclear pore complex channel in isolated neonatal and adult mouse liver nuclei.AQP1 is not only a water channel: It contributes to cell migration through Lin7/beta-cateninRegeneration in distantly related species: common strategies and pathways.Differences between rat dorsal and ventral hippocampus in muscarinic receptor agonist binding and interaction with phospholipase C.Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.Galanin reduces PDBu-induced protein phosphorylation in rat ventral hippocampus.Modeling mechanical control of spindle orientation of intestinal crypt stem cells.Volume Changes During Active Shape Fluctuations in Cells.Effect of a caloric restriction regimen on the angiogenic capacity of aorta and on the expression of endothelin-1 during ageing.Inactivation of PEMT2 in hepatocytes initiated by DENA in fasted/refed rats.Deformation and fracture of echinoderm collagen networks.Gene expression signature of obesity in monozygotic twins.
P50
Q24311939-F27C126C-F759-4478-9663-2C18B915ECF0Q27311999-87D029D4-5881-4EEF-8EE7-59BCD5B12F07Q27320601-E7C20F06-9EFB-4129-B313-DA135EB898B1Q28260876-68DE64A0-7AE6-46EC-84B6-F5B2C33FD897Q30823604-3D009477-E19F-43D2-BDCA-FFA26359E3B7Q33784789-D7E2E214-5DFC-4DC6-BF91-660DED8E2D15Q33860927-785E9986-2EF1-480E-B31A-C2CB753DBD74Q33922318-6FFD51B7-92EE-4245-8BB5-F3752B91782BQ35767900-BBE1C9D1-395F-4338-8072-AC2A73F1D4A2Q35985431-360B0AA1-A4A3-4126-94EC-94BD601C0851Q36418083-16CE1FA6-01C4-4239-ACDD-7F0399B5B1A0Q36737911-3FBB92FF-C406-4DB7-8B78-0720CDACABF9Q36990075-CEA46A47-AD46-4CA7-AF8C-9BD1C5112ED2Q37089056-3DDDD809-7839-4F9B-98E5-73DBA18090D8Q37996774-B5FD7147-ED62-4B7D-B998-07973971C688Q38017150-F33DC0BB-C24A-4F6F-BE47-7742D4801D66Q38721738-B9161613-E3B4-4159-86EB-0296C437AB3CQ38815628-BF484A0D-99EA-4C5D-AEED-FA6D20EDF17FQ38912754-AF37A654-E18B-4D10-9D1B-86ADF0F6AF7AQ39158719-6E9083D9-469A-489A-A40A-6F50F80B7F90Q39711105-FCE04787-0458-4616-A948-D2BD659EC3E2Q40167238-A2396876-81F5-4F55-8C51-2AE83D82ED78Q40419382-3A860EB5-9FBE-4932-9296-1C4648FFF179Q40509205-80C44F73-F70B-4B42-A898-75C9E535B610Q40524814-2FFDD82B-967E-4B3F-9D06-F608A2A8D85AQ41085227-64399628-CAF3-4B30-88D8-5C9F9ED89477Q42034639-16E6EAC3-2C23-494E-A0C3-B5BF3194CFBCQ42460573-13AADCB7-6DA5-4210-8C84-A476733CF703Q42606863-767DB675-F82B-4734-9E0E-D41B30F07EA5Q42735920-53DFC1D8-A61C-41BE-A2D5-6DEE3D2BB817Q48200766-1696FDAD-B15C-417E-BBAB-419EC7C4E71EQ48346085-F7CF1260-6859-420D-BABE-340EAF6C6116Q48419110-7ACE47B9-9A98-459D-8130-163D7BCBE43CQ48506623-CDD9C7F1-9A23-4B89-9433-1C806877414AQ48718258-B974DB68-3F34-4973-A7DD-9744418439AAQ50903485-8B99790F-6E05-4899-8D32-3D45360B5AA6Q51471098-AB17BDE4-67B3-4578-9178-D9C6F2CAAD62Q51496884-15A27AB6-3929-4C91-B491-9341F3498053Q51555462-AA8075F4-32F7-430E-8A23-564347C7526DQ52348257-617FC731-A595-4F5B-888B-C521F48B0E19
P50
description
hulumtuese
@sq
patholoog
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Caterina A. M. La Porta
@de
Caterina La Porta
@en
Caterina La Porta
@es
Caterina La Porta
@nl
type
label
Caterina A. M. La Porta
@de
Caterina La Porta
@en
Caterina La Porta
@es
Caterina La Porta
@nl
prefLabel
Caterina A. M. La Porta
@de
Caterina La Porta
@en
Caterina La Porta
@es
Caterina La Porta
@nl
P214
P227
P244
P5361
P1153
7003555908
P19
P21
P213
0000 0003 7459 5679
P214
P227
1132143349
P244
n2003053102
P2456
P31
P496
0000-0002-3010-8966
P5361
LaPortaCaterina1966-
P569
1966-01-01T00:00:00Z
P7859
lccn-n2003053102